Skip to Content

APO IBA150 (Ibandronate Sodium 150 mg (base))

Pill with imprint APO IBA150 is White, Elliptical / Oval and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Apotex Inc..

Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO IBA150

Ibandronate sodium 150 mg (base) APO IBA150
Ibandronate sodium 150 mg (base) APO IBA150
Ibandronate sodium 150 mg (base) APO IBA150 Front
Ibandronate sodium 150 mg (base) APO IBA150 Back
Ibandronate sodium 150 mg (base) APO IBA150

Ibandronate Sodium

Imprint
APO IBA150
Strength
150 mg (base)
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Inc.
National Drug Code (NDC)
60505-2795

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.